These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6258174)

  • 21. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.
    Atkinson AB; Cumming AM; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1982 Jun; 13(6):855-8. PubMed ID: 7046776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a converting enzyme inhibitor and angiotensin antagonists on the rat pressor effect of angiotensin-like substance formed by goosefish Stannius corpuscles and homologous plasma.
    Pang PK; Yang MC
    Gen Comp Endocrinol; 1981 Nov; 45(3):402-5. PubMed ID: 6271620
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypotensive effect of captopril, an angiotensin converting enzyme inhibitor in pentobarbital anesthetized dogs.
    Satoh S; Fujisawa S; Tanaka R; Nakai K
    Jpn J Pharmacol; 1980 Feb; 30(1):112-5. PubMed ID: 6249947
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of the activity of the angiotensin converting enzyme inhibitors SQ 14 225, SA 446, and MK 421.
    Takata Y; Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE
    Clin Exp Pharmacol Physiol; 1983; 10(2):131-45. PubMed ID: 6307563
    [No Abstract]   [Full Text] [Related]  

  • 25. Dissociation between in vivo and in vitro measurements of converting enzyme activity after chronic oral treatment with captopril in rats.
    Unger T; Hübner D; Schüll B; Yukimura T; Rascher W; Lang RE; Ganten D
    Am J Cardiol; 1982 Apr; 49(6):1530-2. PubMed ID: 6280482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The opposing effects of chronic angiotensin-converting enzyme blockade by captopril on the responses to exogenous angiotensin II and vasopressin vs. norepinephrine in rats.
    Spertini F; Brunner HR; Waeber B; Gavras H
    Circ Res; 1981 May; 48(5):612-8. PubMed ID: 6260396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin and converting enzyme regulate extrarenal salt excretion in ducks.
    Wilson JX; Pham DV; Tan-Wilson HI
    Endocrinology; 1985 Jul; 117(1):135-40. PubMed ID: 2988912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
    McCaa RE
    Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibition of angioten converting enzyme by phosphryl derivatives in rats (author's transl)].
    Mikami H; Ogihara T; Morikawa T; Sakakibara S; Kumahara Y
    Nihon Jinzo Gakkai Shi; 1981 Nov; 23(11):1443-8. PubMed ID: 6278180
    [No Abstract]   [Full Text] [Related]  

  • 32. Analysis of the mechanism of acute decrease of blood pressure induced by captopril (SQ 14,225) in dogs by the use of aprotinin, SAR1-ILE8-angiotensin II and indomethacin.
    Ohara N; Ono H; Hashimoto K
    Jpn Circ J; 1981 Jun; 45(6):672-9. PubMed ID: 6165844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of ACE-inhibition by captopril on renal formation and metabolism of angiotensins I and II in patients with renovascular hypertension.
    Hesse B; Rasmussen S; Giese J; Nielsen MD; Høilund-Carlsen PF
    Scand J Urol Nephrol Suppl; 1984; 79():45-8. PubMed ID: 6089318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cardiac specific analog of angiotensin I potentiated by converting enzyme inhibition.
    Cross RB; Dallemagne C; Beswick E; Khosla MC; Bumpus FM
    Life Sci; 1985 Feb; 36(7):613-8. PubMed ID: 2982072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and pharmacological screening of new angiotensin converting enzyme inhibitors.
    Gubert S; Braso MA; Sacristán A; Ortiz JA
    Farmaco; 1990 Jan; 45(1):59-79. PubMed ID: 2186741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Captopril inhibits pressor responses to peripheral sympathetic nerve activation in cats and rats.
    Boura AL; Hui SC; Rechtman MP; Walters WA
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():123-8. PubMed ID: 6183034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin dependence of captopril-induced drinking after ureteric ligation in the rat.
    Elfont RM; Fitzsimons JT
    J Physiol; 1983 Oct; 343():17-30. PubMed ID: 6358461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological effects of captopril].
    Rubin B; Antonaccio J
    Nouv Presse Med; 1981 Apr; 10(19):1531-46. PubMed ID: 6269555
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of captopril on the reflex control heart rate: possible mechanisms.
    Ajayi AA; Campbell BC; Meredith PA; Kelman AW; Reid JL
    Br J Clin Pharmacol; 1985 Jul; 20(1):17-25. PubMed ID: 2992561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indomethacin does not attenuate the hypotensive effect of captopril, a converting enzyme inhibitor in Goldblatt hypertensive rats.
    Omata K; Otsuka Y; Chiba S; Itoh T; Gotoh T; Imai Y; Sakurai Y; Satoh M; Haruyama T; Hiwatari M; Satoh K; Kaitoh A; Abe K; Yoshinaga K
    Tohoku J Exp Med; 1981 May; 134(1):9-19. PubMed ID: 7031986
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.